Deutsche Börse report key growth figures of the German biotech sector in 2021 in BIOTECH Insight, its new online information service published in collaboration with BIOCOM AG.
According to the results of the Biotechnology Company Survey 2022 conducted by BIOCOM AG (Berlin), the turnover of the German biotech sector grew significantly even after deducting BioNTech revenues.
BIOTECH Insight is a free information service of Deutsche Börse launched in December 2021 in collaboration with BIOCOM AG. Generally, the newsletter covers in-depth news and reports about the German biotech sector along with interviews of CEOs or industry opinion leaders, start-up portraits and background dossiers.
The current issue includes headline results on economic key figures of the sector (based on the BIOCOM report “The German Biotechnology Industry 2021”), an interview with Joachim Kreuzburg, CEO of Sartorius, a dossier on the economic potential of the “bio-based industry”, current news as well as profiles of relevant start-ups, investors and biotech locations.
“With BIOTECH Insight we want to create more visibility for the development of this attractive tech sector, map trends and topics as well as relevant players – also beyond the healthcare industry”, Peter Fricke, Head of Capital Markets Sales, Deutsche Börse AG, explains the approach.
The BIOTECH Insight newsletter is sent out twice a year, subscription is possible at any time: